参考文献:1.McGlynn KA, London WT (2011) The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15(2):223–243PubMedCentral CrossRef PubMed 2.Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90CrossRef PubMed 3.Nordenstedt H, White DL, El-Serag HB (2010) The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 42(Suppl 3):S206–S214PubMedCentral CrossRef PubMed 4.Center MM, Jemal A (2011) International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev 20(11):2362–2368CrossRef PubMed 5.El-Serag HB, Kanwal F (2014) Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 60(5):1767–1775PubMedCentral CrossRef PubMed 6.Gordon AC, Lewandowski RJ, Salem R, et al. (2014) Localized hyperthermia with iron oxide-doped yttrium microparticles: steps toward image-guided thermoradiotherapy in liver cancer. J Vasc Interv Radiol 25(3):397–404PubMedCentral CrossRef PubMed 7.Choi JW, Kim H, Kim HC, et al. (2013) Blood oxygen level-dependent MRI for evaluation of early response of liver tumors to chemoembolization: an animal study. Anticancer Res 33(5):1887–1892PubMed 8.Thompson SM, Callstrom MR, Knudsen B, et al. (2013) AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry. Cardiovasc Intervent Radiol 36(1):198–203PubMedCentral CrossRef PubMed 9.Lee TK, Na KS, Kim J, Jeong HJ (2014) Establishment of animal models with orthotopic hepatocellular carcinoma. Nucl Med Mol Imaging 48(3):173–179PubMedCentral CrossRef PubMed 10.Suda T, Liu D (2007) Hydrodynamic gene delivery: its principles and applications. Mol Ther 15(12):2063–2069CrossRef PubMed 11.Du Z, Wei C, Cheng K, et al. (2013) Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. J Surg Res 183(2):907–915CrossRef PubMed 12.Cho HR, Choi JW, Kim HC, et al. (2013) Sprague-Dawley rats bearing McA-RH7777 cells for study of hepatoma and transarterial chemoembolization. Anticancer Res 33(1):223–230PubMed 13.Mouli SK, Tyler P, McDevitt JL, et al. (2013) Image-guided local delivery strategies enhance therapeutic nanoparticle uptake in solid tumors. ACS Nano 7(9):7724–7733PubMedCentral CrossRef PubMed 14.Guo Y, Jin N, Klein R, et al. (2012) Gas challenge-blood oxygen level-dependent (GC-BOLD) MRI in the rat Novikoff hepatoma model. Magn Reson Imaging 30(1):133–138PubMedCentral CrossRef PubMed 15.Wang YX, Yuan J, Chu ES, et al. (2011) T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology 259(3):712–719CrossRef PubMed 16.Choi JW, Kim HC, Baek SY, Ryu YJ, Chung JW (2015) A metastatic hepatoma model of rats using the 13762-MAT-B-III cell line: basic characteristics and potential as a tool for interventional oncology experiments. Anticancer Res 35(3):1333–1338PubMed 17.Buijs M, Geschwind JF, Syed LH, et al. (2012) Spontaneous tumor regression in a syngeneic rat model of liver cancer: implications for survival studies. J Vasc Interv Radiol 23(12):1685–1691PubMedCentral CrossRef PubMed 18.Guo Y, Klein R, Omary RA, Yang GY, Larson AC (2010) Highly malignant intra-hepatic metastatic hepatocellular carcinoma in rats. Am J Transl Res 3(1):114–120PubMedCentral PubMed 19.Bokor D (2000) Diagnostic efficacy of SonoVue. Am J Cardiol 86(4A):19G–24GCrossRef PubMed 20.Joo I, Kim JH, Lee JM, et al. (2014) Early quantification of the therapeutic efficacy of the vascular disrupting agent, CKD-516, using dynamic contrast-enhanced ultrasonography in rabbit VX2 liver tumors. Ultrasonography 33(1):18–25PubMedCentral CrossRef PubMed 21.Lassau N, Koscielny S, Chami L, et al. (2011) Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification–preliminary results. Radiology 258(1):291–300CrossRef PubMed 22.Kim HC, Chung JW, Choi SH, et al. (2012) Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model. Cardiovasc Intervent Radiol 35(1):168–175CrossRef PubMed 23.Tanigawa N, Lu C, Mitsui T, Miura S (1997) Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 26(5):1216–1223PubMed 24.Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022PubMedCentral CrossRef PubMed 25.European Association For The Study Of The Liver, European Organisation For Research and Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56(4):908–943CrossRef 26.Sica GT, Ji H, Ros PR (2000) CT and MR imaging of hepatic metastases. AJR Am J Roentgenol 174(3):691–698CrossRef PubMed 27.Kong WT, Yuan HX, Cai H, et al. (2015) Early treatment response to sorafenib for rabbit VX2 orthotic liver tumors: evaluation by quantitative contrast-enhanced ultrasound. Tumour Biol 36(4):2593–2599CrossRef PubMed
作者单位:Jin Woo Choi (1) Jung Hoon Kim (1) Hyo-Cheol Kim (1) Won Seok Choi (1) Song Yi Baek (1) Kyoungbun Lee (2) Jin Wook Chung (1)
1. Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Republic of Korea 2. Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
刊物类别:Medicine
刊物主题:Medicine & Public Health Imaging and Radiology Gastroenterology Hepatology
出版者:Springer New York
ISSN:1432-0509
文摘
Purpose To compare tumor vascularity and hemodynamics in three rat hepatoma models: N1-S1 cells in Sprague–Dawley rats, McA-RH7777 cells in Sprague–Dawley rats, and 13762 MAT B III cells in F344 rats.